Trial intelligence / Profile preview

Letrozole vs Methotrexate for Treatment of Unruptured Ectopic Pregnancy

TCTR20250117002Phase 3Not yet recruiting

Sponsor
Buriram Hospital
Start
Mar 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of letrozole, methotrexate in Ectopic pregnancy (EP), sponsored by Buriram Hospital. Planned start Mar 2025; status: not yet recruiting.

02

Drugs

letrozolemethotrexate
03

Conditions

Ectopic pregnancy (EP)

Beyond the preview

Go deeper on TCTR20250117002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250117002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call